Extended Input Deadline for USP´s new Chapter on Quality Considerations for Cannabis

Following the previously announced elaboration of a new USP chapter <1568> Quality Considerations for Cannabis and Cannabis-derived Products for Clinical Research the input deadline has been extended to 31 July 2022.

USP is requesting early input from stakeholders on the proposed new General Chapter <1568> which is then expected to be published for comment in Pharmacopeial Forum.

More Information is available at the USP Compendial Notices Website.